“XYZ Biotech: A Fictional Business Development Case Utilizing Quantitative Tools to Evaluate a New Antibody-Drug-Conjugate Opportunity for Metastatic Breast Cancer”, AJM, vol. 23, no. 5, Dec. 2023, Accessed: Mar. 16, 2026. [Online]. Available: https://articlearchives.co/index.php/AJM/article/view/6109